Practical Guide to Stock Rights Protection (Civil Compensation for Securities Fraudulent Misrepresentation)

I. What Is Stock Rights Protection? Stock rights protection generally refers to civil redress actions whereby investors, having suffered losses due to illegal acts committed by listed companies—such as fraudulent misrepresentation, fraudulent issuance, insider trading, or market manipulation—lawfully seek compensation from responsible parties. Currently, the most common and institutionally supported type is disputes concerning liability for securities fraudulent misrepresentation. Common forms of misrepresentation include: fabrication of financial statements; failure to disclose material events; misleading statements; and grossly inaccurate profit forecasts. II. Three Conditions That Must All Be Met for Claiming Compensation III. Four Key Time Points IV. Scope of Compensable Losses Pursuant to Article 25 of the Provisions on Several Issues Concerning Civil Compensation for Fraudulent Misrepresentation, the scope of compensation is limited to investors’ actual losses, including: 1. Investment differential loss (the core component)—calculated as the difference between the average purchase price and the average sale price (or benchmark price), multiplied by the number of shares held; 2. Commission fees and stamp duty corresponding to the investment differential loss; 3. Interest losses on the above amounts (calculated at the prevailing interest rate for demand deposits with commercial banks). V. Channels for Rights Protection (from lowest to highest cost) VI. Statute of Limitations VII. Documents Required for Filing a Lawsuit 1. Identity documents: photocopy of ID card (for individual investors) or business license (for institutional investors); 2. Evidence of fraudulent misrepresentation: administrative penalty decision issued by the China Securities Regulatory Commission (CSRC), company announcements, notices of investigation initiation, etc. (if available); 3. Transaction records: securities account information and trade statements (stamped with the official seal of the securities firm’s branch office), containing dates, quantities, and prices of purchases and sales;

No Recovery, No Fee! Rosen Law Firm Explains Securities Class Actions

Many investors have heard of 'securities class actions' but may not truly understand what they are—or how they can benefit them. Today, we’ve compiled answers to several of the most frequently asked questions to help you quickly grasp the essentials 👇 1️⃣ What Is a Securities Class Action? 👉 In simple terms, it is a legal mechanism whereby investors collectively sue a company for damages after suffering losses caused by the company’s fraudulent misrepresentation, financial fraud, or inaccurate disclosure—actions that led to a decline in its stock price. 2️⃣ What Is the 'Class Period'? 👉 It refers to the time period during which the stock price was artificially inflated by false or misleading information. Only investors who purchased shares during this period—and subsequently incurred losses—are eligible to join the lawsuit and receive compensation. 3️⃣ What Is a 'Lead Plaintiff'? 👉 A lead plaintiff serves as the 'representative' or 'spokesperson' for the entire class of injured investors. Appointed by the court, the lead plaintiff typically suffers the largest losses—but any eventual victory and resulting compensation will benefit all qualified investors. 4️⃣ Advantages of Securities Class Actions ✔ Investors do not need to file individual lawsuits—saving time and effort; ✔ Contingency-fee representation: no upfront legal costs for investors; ✔ Even relatively small claims can be recovered collectively through a class action.

Securities Fraud Class Action Filed Against Chemours Company

Oct 24, 2026

Chemours Co. faces a securities class action lawsuit alleging overstated demand for Opteon products. Investors who purchased shares between February and August 2026 have until December 7, 2026, to seek recovery.

ACCESS Newswire

2026-10-09

Chemours Company Faces Securities Fraud Class Action Over Opteon Demand Claims

2026-10-11

Chemours Faces Securities Lawsuit Over Disclosures and Guidance

2026-10-11

Chemours Company Faces Class Action Lawsuit Alleging Investor Harm

2026-10-12

Class Action Lawsuit Filed Against Chemours for Misleading Investors on Product Demand and Financial Guidance.

2026-10-12

Class Action Lawsuit Filed Against Chemours Over Overstated Demand and Lowered 2026 Guidance